An Unusual Case of Non-classical 21-Hydroxylase Deficiency Presenting with Hypercortisolemia and Hyperandrogenemia: A Case Report

Abstract Background Non-classical 21-hydroxylase deficiency (NC-21OHD) typically presents with hyperandrogenemia and low-to-normal cortisol levels. However, elevated cortisol levels are exceedingly rare and may lead to diagnostic confusion with Cushing's syndrome. Case Presentation: We report a 25-year-old woman who presented with a three-month history of menstrual irregularities. Physical examination revealed a full-moon face, hirsutism, male-pattern pubic hair distribution, and clitoral hypertrophy. Laboratory investigations demonstrated hypercortisolemia (serum cortisol: 27.98 µg/dL at 8 AM; urinary free cortisol: 264.38 µg/24h) and hyperandrogenemia (testosterone: 1.25 ng/mL; DHEA-S: 1025 µg/dL). Enhanced computed tomography revealed bilateral adrenal thickening. Although these findings initially suggested Cushing's syndrome, low-dose dexamethasone suppression testing markedly suppressed both cortisol (15.88 → 0.63 µg/dL) and testosterone (1.25 → 0.63 ng/mL), effectively excluding Cushing's syndrome and indicating an adrenal source of hyperandrogenemia. Notably, basal 17-hydroxyprogesterone (17-OHP) was within the normal range (0.77 ng/mL), but cosyntropin stimulation elevated 17-OHP to 11.54 ng/mL. Subsequent genetic testing confirmed CYP21A2 mutations, establishing the diagnosis of NC-21OHD. Glucocorticoid therapy with prednisone (2.5 mg nightly) normalized menstrual cycles and androgen levels within one month, with follow-up imaging showing significant adrenal size reduction at six months. Conclusions This case highlights that hypercortisolemia can occur in NC-21OHD and may coexist with features mimicking Cushing's syndrome. The combination of low-dose dexamethasone suppression testing—to simultaneously exclude Cushing's syndrome and confirm adrenal-derived hyperandrogenemia—followed by ACTH stimulation testing and genetic confirmation, represents a critical diagnostic pathway. Clinicians should maintain heightened awareness of this atypical presentation to avoid misdiagnosis.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-11
DOI
https://doi.org/10.21203/rs.3.rs-11193749/v1
Primary Topic
Sexual Differentiation and Disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

An Unusual Case of Non-classical 21-Hydroxylase Deficiency Presenting with Hypercortisolemia and Hyperandrogenemia: A Case Report

Yunfei Pan, Yujia Qiu, Jianping Yao, Longqi Zhang
Research Square
Sexual Differentiation and Disorders
preprint

An Unusual Case of Non-classical 21-Hydroxylase Deficiency Presenting with Hypercortisolemia and Hyperandrogenemia: A Case Report

Yunfei Pan, Yujia Qiu, Jianping Yao, Longqi Zhang
preprint en

Abstract

Abstract Background Non-classical 21-hydroxylase deficiency (NC-21OHD) typically presents with hyperandrogenemia and low-to-normal cortisol levels. However, elevated cortisol levels are exceedingly rare and may lead to diagnostic confusion with Cushing's syndrome. Case Presentation: We report a 25-year-old woman who presented with a three-month history of menstrual irregularities. Physical examination revealed a full-moon face, hirsutism, male-pattern pubic hair distribution, and clitoral hypertrophy. Laboratory investigations demonstrated hypercortisolemia (serum cortisol: 27.98 µg/dL at 8 AM; urinary free cortisol: 264.38 µg/24h) and hyperandrogenemia (testosterone: 1.25 ng/mL; DHEA-S: 1025 µg/dL). Enhanced computed tomography revealed bilateral adrenal thickening. Although these findings initially suggested Cushing's syndrome, low-dose dexamethasone suppression testing markedly suppressed both cortisol (15.88 → 0.63 µg/dL) and testosterone (1.25 → 0.63 ng/mL), effectively excluding Cushing's syndrome and indicating an adrenal source of hyperandrogenemia. Notably, basal 17-hydroxyprogesterone (17-OHP) was within the normal range (0.77 ng/mL), but cosyntropin stimulation elevated 17-OHP to 11.54 ng/mL. Subsequent genetic testing confirmed CYP21A2 mutations, establishing the diagnosis of NC-21OHD. Glucocorticoid therapy with prednisone (2.5 mg nightly) normalized menstrual cycles and androgen levels within one month, with follow-up imaging showing significant adrenal size reduction at six months. Conclusions This case highlights that hypercortisolemia can occur in NC-21OHD and may coexist with features mimicking Cushing's syndrome. The combination of low-dose dexamethasone suppression testing—to simultaneously exclude Cushing's syndrome and confirm adrenal-derived hyperandrogenemia—followed by ACTH stimulation testing and genetic confirmation, represents a critical diagnostic pathway. Clinicians should maintain heightened awareness of this atypical presentation to avoid misdiagnosis.

Research Square
Huzhou Central Hospital (CN)
Sexual Differentiation and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon